Viral envelope glycoprotein processing by proprotein convertases

Antiviral Research

Volumn 99, Issue 1, 2013, Pages 49-60

  Pasquato, Antonella ^a   de Palma, Joel Ramosda ^a   Galan, Clara ^a   Seidah, Nabil G ^b   Kunz, Stefan ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; ANTIVIRUS AGENT; FURIN; INFLUENZA VIRUS HEMAGGLUTININ; MEMBRANE PROTEIN; PF 429242; SERINE PROTEINASE; TRYPSIN INHIBITOR; UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN;

ALPHA VIRUS; ANTIVIRAL THERAPY; CELL FUNCTION; CELL MEMBRANE; CHOLESTEROL BLOOD LEVEL; ENDOPLASMIC RETICULUM; ENDOSOME; ENZYME ACTIVITY; HOMEOSTASIS; HOST CELL; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; INFLUENZA VIRUS A; MEASLES VIRUS; MOLECULAR MECHANICS; NONHUMAN; PARAMYXOVIRUS; PATHOGENESIS; POINT MUTATION; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN PROCESSING; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; SENDAI VIRUS; TRANS GOLGI NETWORK; VIRUS CELL INTERACTION;

MAMMALIA;

EID: 84878237040     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2013.04.013     Document Type: Review

References (154)

1. Alkhatib, G., Roder, J., Richardson, C., Briedis, D., Weinberg, R., Smith, D., Taylor, J., Paoletti, E., Shen, S.H., 1994. Characterization of a cleavage mutant of the measles virus fusion protein defective in syncytium formation. J. Virol. 68, 6770-6774.
2. Altamura, L.A., Bertolotti-Ciarlet, A., Teigler, J., Paragas, J., Schmaljohn, C.S., Doms, R.W., 2007. Identification of a novel C-terminal cleavage of Crimean-Congo hemorrhagic fever virus PreGN that leads to generation of an NSM protein. J. Virol. 81, 6632-6642.
3. Anderson, E.D., Thomas, L., Hayflick, J.S., Thomas, G., 1993. Inhibition of HIV-1 gp160-dependent membrane fusion by a furin-directed alpha 1-antitrypsin variant. J. Biol. Chem. 268, 24887-24891.
4. Bahbouhi, B., Bendjennat, M., Guetard, D., Seidah, N.G., Bahraoui, E., 2000. Effect of alpha-1 antitrypsin Portland variant (alpha 1-PDX) on HIV-1 replication. Biochem. J. 352 (Pt 1), 91-98.
5. Bahbouhi, B., Seidah, N.G., Bahraoui, E., 2001. Replication of HIV-1 viruses in the presence of the Portland alpha1-antitrypsin variant (alpha1-PDX) inhibitor. Biochem. J. 360, 127-134.
6. Barbouche, R., Sabatier, J.M., Fenouillet, E., 1998. An anti-HIV peptide construct derived from the cleavage region of the Env precursor acts on Env fusogenicity through the presence of a functional cleavage sequence. Virology 247, 137-143.
7. Barbouche, R., Decroly, E., Kieny, M.P., Fenouillet, E., 2000. An anti-human immunodeficiency virus multiple antigen peptide encompassing the cleavage region of the env precursor interferes with membrane fusion at a post-CD4 binding step. Virology 273, 169-177.
8. Barr, P.J., 1991. Mammalian subtilisins: the long-sought dibasic processing endoproteases. Cell 66, 1-3.
9. Basak, A., Toure, B.B., Lazure, C., Mbikay, M., Chretien, M., Seidah, N.G., 1999. Enzymic characterization in vitro of recombinant proprotein convertase PC4. Biochem. J. 343 (Pt 1), 29-37.
10. Basak, A., Zhong, M., Munzer, J.S., Chretien, M., Seidah, N.G., 2001. Implication of the proprotein convertases furin, PC5 and PC7 in the cleavage of surface glycoproteins of Hong Kong, Ebola and respiratory syncytial viruses: a comparative analysis with fluorogenic peptides. Biochem. J. 353, 537-545.
11. Bass, J., Turck, C., Rouard, M., Steiner, D.F., 2000. Furin-mediated processing in the early secretory pathway: sequential cleavage and degradation of misfolded insulin receptors. Proc. Natl. Acad. Sci. USA 97, 11905-11909.
12. Becker, G.L., Sielaff, F., Than, M.E., Lindberg, I., Routhier, S., Day, R., Lu, Y., Garten, W., Steinmetzer, T., 2010. Potent inhibitors of furin and furin-like proprotein convertases containing decarboxylated P1 arginine mimetics. J. Med. Chem. 53, 1067-1075.
13. Becker, G.L., Lu, Y., Hardes, K., Strehlow, B., Levesque, C., Lindberg, I., Sandvig, K., Bakowsky, U., Day, R., Garten, W., Steinmetzer, T., 2012. Highly potent inhibitors of proprotein convertase furin as potential drugs for treatment of infectious diseases. J. Biol. Chem. 287, 21992-22003.
14. Benjannet, S., Elagoz, A., Wickham, L., Mamarbachi, M., Munzer, J.S., Basak, A., Lazure, C., Cromlish, J.A., Sisodia, S., Checler, F., Chretien, M., Seidah, N.G., 2001. Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem. 276, 10879-10887.
15. Benjannet, S., Rhainds, D., Essalmani, R., Mayne, J., Wickham, L., Jin, W., Asselin, M.C., Hamelin, J., Varret, M., Allard, D., Trillard, M., Abifadel, M., Tebon, A., Attie, A.D., Rader, D.J., Boileau, C., Brissette, L., Chretien, M., Prat, A., Seidah, N.G., 2004. NARC-1/PCSK9 and its natural mutants: zymogen cleavage and effects on the low density lipoprotein (LDL) receptor and LDL cholesterol. J. Biol. Chem. 279, 48865-48875.
16. Bergeron, E., Vincent, M.J., Nichol, S.T., 2007. Crimean-Congo hemorrhagic fever virus glycoprotein processing by the endoprotease SKI-1/S1P is critical for virus infectivity. J. Virol. 81, 13271-13276.
17. Beyer, W.R., Popplau, D., Garten, W., von Laer, D., Lenz, O., 2003. Endoproteolytic processing of the lymphocytic choriomeningitis virus glycoprotein by the subtilase SKI-1/S1P. J. Virol. 77, 2866-2872.
18. Bolt, G., Pedersen, I.R., 1998. The role of subtilisin-like proprotein convertases for cleavage of the measles virus fusion glycoprotein in different cell types. Virology 252, 387-398.
19. Bonthius, D.J., Perlman, S., 2007. Congenital viral infections of the brain: lessons learned from lymphocytic choriomeningitis virus in the neonatal rat. PLoS Pathog. 3, e149.
20. Bonthius, D.J., Nichols, B., Harb, H., Mahoney, J., Karacay, B., 2007. Lymphocytic choriomeningitis virus infection of the developing brain: critical role of host age. Ann. Neurol. 62, 356-374.
21. Borrow, P., Oldstone, M.B., 1992. Characterization of lymphocytic choriomeningitis virus-binding protein(s): a candidate cellular receptor for the virus. J. Virol. 66, 7270-7281.
22. Bosch, V., Pawlita, M., 1990. Mutational analysis of the human immunodeficiency virus type 1 env gene product proteolytic cleavage site. J. Virol. 64, 2337-2344.
23. Bottcher-Friebertshauser, E., Freuer, C., Sielaff, F., Schmidt, S., Eickmann, M., Uhlendorff, J., Steinmetzer, T., Klenk, H.D., Garten, W., 2010. Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors. J. Virol. 84, 5605-5614.
24. Bottcher-Friebertshauser, E., Stein, D.A., Klenk, H.D., Garten, W., 2011. Inhibition of influenza virus infection in human airway cell cultures by an antisense peptideconjugated morpholino oligomer targeting the hemagglutinin-activating protease TMPRSS2. J. Virol. 85, 1554-1562.
25. Briese, T., Paweska, J.T., McMullan, L.K., Hutchison, S.K., Street, C., Palacios, G., Khristova, M.L., Weyer, J., Swanepoel, R., Egholm, M., Nichol, S.T., Lipkin, W.I., 2009. Genetic detection and characterization of Lujo virus, a new hemorrhagic fever-associated arenavirus from Southern Africa. PLoS Pathog. 5, e1000455.
26. Buchmeier, M.J., de la Torre, J.C., Peters, C.J., 2007. Arenaviridae: the viruses and their replication. In: Knipe, D.L., Howley, P.M. (Eds.), Fields Virology. Lippincott- Raven, Philadelphia, pp. 1791-1828.
27. Burri, D.J., Pasqual, G., Rochat, C., Seidah, N.G., Pasquato, A., Kunz, S., 2012. Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease. J. Virol. 86, 4935-4946.
28. Cameron, A., Appel, J., Houghten, R.A., Lindberg, I., 2000. Polyarginines are potent furin inhibitors. J. Biol. Chem. 275, 36741-36749.
29. Chan, D.C., Fass, D., Berger, J.M., Kim, P.S., 1997. Core structure of gp41 from the HIV envelope glycoprotein. Cell 89, 263-273.
30. Charrel, R.N., de Lamballerie, X., Emonet, S., 2008. Phylogeny of the genus Arenavirus. Curr. Opin. Microbiol. 11, 362-368.
31. Chen, J., Lee, K.H., Steinhauer, D.A., Stevens, D.J., Skehel, J.J., Wiley, D.C., 1998. Structure of the hemagglutinin precursor cleavage site, a determinant of influenza pathogenicity and the origin of the labile conformation. Cell 95, 409- 417.
32. Cox, N.J., Fuller, F., Kaverin, N., Klenk, H.D., Lamb, R.A., Mahy, B.W.J., McCauley, J., Nakamura, K., Palese, P., Webster, R.G., 2000. Family Orthomyxoviridae in Virus Taxonomy. Seventh Report of the International Committee on Taxonomy of Viruses. Academic Press, San Diego, CA.
33. Creemers, J.W., Khatib, A.M., 2008. Knock-out mouse models of proprotein convertases: unique functions or redundancy? Front. Biosci. 13, 4960-4971.
34. De Bie, I., Marcinkiewicz, M., Malide, D., Lazure, C., Nakayama, K., Bendayan, M., Seidah, N.G., 1996. The isoforms of proprotein convertase PC5 are sorted to different subcellular compartments. J. Cell Biol. 135, 1261-1275.
35. Decha, P., Rungrotmongkol, T., Intharathep, P., Malaisree, M., Aruksakunwong, O., Laohpongspaisan, C., Parasuk, V., Sompornpisut, P., Pianwanit, S., Kokpol, S., Hannongbua, S., 2008. Source of high pathogenicity of an avian influenza virus H5N1: why H5 is better cleaved by furin. Biophys. J. 95, 128-134.
36. Decroly, E., Vandenbranden, M., Ruysschaert, J.M., Cogniaux, J., Jacob, G.S., Howard, S.C., Marshall, G., Kompelli, A., Basak, A., Jean, F., et al., 1994. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-I TM). J. Biol. Chem. 269, 12240-12247.
37. Decroly, E., Benjannet, S., Savaria, D., Seidah, N.G., 1997. Comparative functional role of PC7 and furin in the processing of the HIV envelope glycoprotein gp160. FEBS Lett. 405, 68-72.
38. Delgado, S., Erickson, B.R., Agudo, R., Blair, P.J., Vallejo, E., Albarino, C.G., Vargas, J., Comer, J.A., Rollin, P.E., Ksiazek, T.G., Olson, J.G., Nichol, S.T., 2008. Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia. PLoS Pathog. 4, e1000047.
39. Diederich, S., Thiel, L., Maisner, A., 2008. Role of endocytosis and cathepsinmediated activation in Nipah virus entry. Virology 375, 391-400.
40. Dillon, S.L., Williamson, D.M., Elferich, J., Radler, D., Joshi, R., Thomas, G., Shinde, U., 2012. Propeptides are sufficient to regulate organelle-specific pHdependent activation of furin and proprotein convertase 1/3. J. Mol. Biol. 423, 47-62.
41. Dubay, J.W., Dubay, S.R., Shin, H.J., Hunter, E., 1995. Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J. Virol. 69, 4675-4682.
42. Eichler, R., Lenz, O., Strecker, T., Eickmann, M., Klenk, H.D., Garten, W., 2003a. Identification of Lassa virus glycoprotein signal peptide as a trans-acting maturation factor. EMBO Rep. 4, 1084-1088.
43. Eichler, R., Lenz, O., Strecker, T., Garten, W., 2003b. Signal peptide of Lassa virus glycoprotein GP-C exhibits an unusual length. FEBS Lett. 538, 203-206.
44. Elshuber, S., Allison, S.L., Heinz, F.X., Mandl, C.W., 2003. Cleavage of protein prM is necessary for infection of BHK-21 cells by tick-borne encephalitis virus. J. Gen. Virol. 84, 183-191.
45. Ergonul, O., 2006. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 6, 203- 214.
46. Eschli, B., Quirin, K., Wepf, A., Weber, J., Zinkernagel, R., Hengartner, H., 2006. Identification of an N-terminal trimeric coiled-coil core within arenavirus glycoprotein 2 permits assignment to class I viral fusion proteins. J. Virol. 80, 5897-5907.
47. Essalmani, R., Zaid, A., Marcinkiewicz, J., Chamberland, A., Pasquato, A., Seidah, N.G., Prat, A., 2008. In vivo functions of the proprotein convertase PC5/6 during mouse development: Gdf11 is a likely substrate. Proc. Natl. Acad. Sci. USA 105, 5750-5755.
48. Falcigno, L., Oliva, R., D'Auria, G., Maletta, M., Dettin, M., Pasquato, A., Di Bello, C., Paolillo, L., 2004. Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site 3: role of site-specific mutations. Chembiochem 5, 1653- 1661.
49. Fenouillet, E., Gluckman, J.C., 1992. Immunological analysis of human immunodeficiency virus type 1 envelope glycoprotein proteolytic cleavage. Virology 187, 825-828.
50. Fischer, S.A., Graham, M.B., Kuehnert, M.J., Kotton, C.N., Srinivasan, A., Marty, F.M., Comer, J.A., Guarner, J., Paddock, C.D., DeMeo, D.L., Shieh, W.J., Erickson, B.R., Bandy, U., DeMaria Jr., A., Davis, J.P., Delmonico, F.L., Pavlin, B., Likos, A., Vincent, M.J., Sealy, T.K., Goldsmith, C.S., Jernigan, D.B., Rollin, P.E., Packard, M.M., Patel, M., Rowland, C., Helfand, R.F., Nichol, S.T., Fishman, J.A., Ksiazek, T., Zaki, S.R., 2006. Transmission of lymphocytic choriomeningitis virus by organ transplantation. N. Engl. J. Med. 354, 2235-2249.
51. Froeschke, M., Basler, M., Groettrup, M., Dobberstein, B., 2003. Long-lived signal peptide of lymphocytic choriomeningitis virus glycoprotein pGP-C. J. Biol. Chem. 278, 41914-41920 (Epub 2003 Aug 12).
52. Fujinami, R.S., Oldstone, M.B., 1981. Failure to cleave measles virus fusion protein in lymphoid cells. J. Exp. Med. 154, 1489-1499.
53. Garten, W., Klenk, H.D., 1983. Characterization of the carboxypeptidase involved in the proteolytic cleavage of the influenza haemagglutinin. J. Gen. Virol. 64 (Pt 10), 2127-2137.
54. Garten, W., Hallenberger, S., Ortmann, D., Schafer, W., Vey, M., Angliker, H., Shaw, E., Klenk, H.D., 1994. Processing of viral glycoproteins by the subtilisin-like endoprotease furin and its inhibition by specific peptidylchloroalkylketones. Biochimie 76, 217-225.
55. Geisbert, T.W., Jahrling, P.B., 2004. Exotic emerging viral diseases: progress and challenges. Nat. Med. 10, S110-S121.
56. Gonzalez-Reyes, L., Ruiz-Arguello, M.B., Garcia-Barreno, B., Calder, L., Lopez, J.A., Albar, J.P., Skehel, J.J., Wiley, D.C., Melero, J.A., 2001. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc. Natl. Acad. Sci. USA 98, 9859-9864.
57. Gotoh, B., Ohnishi, Y., Inocencio, N.M., Esaki, E., Nakayama, K., Barr, P.J., Thomas, G., Nagai, Y., 1992. Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3. J. Virol. 66, 6391-6397.
58. Gould, E.A., Solomon, T., 2008. Pathogenic flaviviruses. Lancet 371, 500-509.
59. Gould, E.A., Coutard, B., Malet, H., Morin, B., Jamal, S., Weaver, S., Gorbalenya, A., Moureau, G., Baronti, C., Delogu, I., Forrester, N., Khasnatinov, M., Gritsun, T., de Lamballerie, X., Canard, B., 2010. Understanding the alphaviruses: recent research on important emerging pathogens and progress towards their control. Antiviral Res. 87, 111-124.
60. Gyamera-Acheampong, C., Tantibhedhyangkul, J., Weerachatyanukul, W., Tadros, H., Xu, H., van de Loo, J.W., Pelletier, R.M., Tanphaichitr, N., Mbikay, M., 2006. Sperm from mice genetically deficient for the PCSK4 proteinase exhibit accelerated capacitation, precocious acrosome reaction, reduced binding to egg zona pellucida, and impaired fertilizing ability. Biol. Reprod. 74, 666-673.
61. Hada, K., Isshiki, K., Matsuda, S., Yuasa, K., Tsuji, A., 2012. Engineering of alpha1- antitrypsin variants with improved specificity for the proprotein convertase furin using site-directed random mutagenesis. Protein Eng. Des. Sel. 26, 123- 131.
62. Haferkamp, S., Fernando, L., Schwarz, T.F., Feldmann, H., Flick, R., 2005. Intracellular localization of Crimean-Congo Hemorrhagic Fever (CCHF) virus glycoproteins. Virol. J. 2, 42.
63. Hallenberger, S., Bosch, V., Angliker, H., Shaw, E., Klenk, H.D., Garten, W., 1992. Inhibition of furin-mediated cleavage activation of HIV-1 glycoprotein gp160. Nature 360, 358-361.
64. Halstead, S.B., 2007. Dengue. Lancet 370, 1644-1652.
65. Hamilton, B.S., Sun, X., Chung, C., Whittaker, G.R., 2012. Acquisition of a novel eleven amino acid insertion directly N-terminal to a tetrabasic cleavage site confers intracellular cleavage of an H7N7 influenza virus hemagglutinin. Virology 434, 88-95.
66. Hawkins, J.L., Robbins, M.D., Warren, L.C., Xia, D., Petras, S.F., Valentine, J.J., Varghese, A.H., Wang, I.K., Subashi, T.A., Shelly, L.D., Hay, B.A., Landschulz, K.T., Geoghegan, K.F., Harwood Jr., H.J., 2008. Pharmacologic inhibition of site 1 protease activity inhibits sterol regulatory element-binding protein processing and reduces lipogenic enzyme gene expression and lipid synthesis in cultured cells and experimental animals. J. Pharmacol. Exp. Ther. 326, 801-808.
67. Hay, B.A., Abrams, B., Zumbrunn, A.Y., Valentine, J.J., Warren, L.C., Petras, S.F., Shelly, L.D., Xia, A., Varghese, A.H., Hawkins, J.L., Van Camp, J.A., Robbins, M.D., Landschulz, K., Harwood Jr., H.J., 2007. Aminopyrrolidineamide inhibitors of site-1 protease. Bioorg. Med. Chem. Lett. 17, 4411-4414.
68. Heidner, H.W., McKnight, K.L., Davis, N.L., Johnston, R.E., 1994. Lethality of PE2 incorporation into Sindbis virus can be suppressed by second-site mutations in E3 and E2. J. Virol. 68, 2683-2692.
69. Henrich, S., Lindberg, I., Bode, W., Than, M.E., 2005. Proprotein convertase models based on the crystal structures of furin and kexin: explanation of their specificity. J. Mol. Biol. 345, 211-227.
70. Homma, M., Ouchi, M., 1973. Trypsin action on the growth of Sendai virus in tissue culture cells. 3. Structural difference of Sendai viruses grown in eggs and tissue culture cells. J. Virol. 12, 1457-1465.
71. Horimoto, T., Kawaoka, Y., 1995. Molecular changes in virulent mutants arising from avirulent avian influenza viruses during replication in 14-day-old embryonated eggs. Virology 206, 755-759.
72. Horimoto, T., Nakayama, K., Smeekens, S.P., Kawaoka, Y., 1994. Proproteinprocessing endoproteases PC6 and furin both activate hemagglutinin of virulent avian influenza viruses. J. Virol. 68, 6074-6078.
73. Horvath, C.M., Paterson, R.G., Shaughnessy, M.A., Wood, R., Lamb, R.A., 1992. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J. Virol. 66, 4564-4569.
74. Igonet, S., Vaney, M.C., Vonhrein, C., Bricogne, G., Stura, E.A., Hengartner, H., Eschli, B., Rey, F.A., 2011. X-ray structure of the arenavirus glycoprotein GP2 in its postfusion hairpin conformation. Proc. Natl. Acad. Sci. USA 108, 19967-19972.
75. Izidoro, M.A., Assis, D.M., Oliveira, V., Santos, J.A., Juliano, M.A., Lindberg, I., Juliano, L., 2010. Effects of magnesium ions on recombinant human furin: selective activation of hydrolytic activity upon substrates derived from virus envelope glycoprotein. Biol. Chem. 391, 1105-1112.
76. Kan, C.C., Solomon, E., Belt, K.T., Chain, A.C., Hiorns, L.R., Fey, G., 1985. Nucleotide sequence of cDNA encoding human alpha 2-macroglobulin and assignment of the chromosomal locus. Proc. Natl. Acad. Sci. USA 82, 2282-2286.
77. Karron, R.A., Buonagurio, D.A., Georgiu, A.F., Whitehead, S.S., Adamus, J.E., Clements-Mann, M.L., Harris, D.O., Randolph, V.B., Udem, S.A., Murphy, B.R., Sidhu, M.S., 1997. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc. Natl. Acad. Sci. USA 94, 13961-13966.
78. Keelapang, P., Sriburi, R., Supasa, S., Panyadee, N., Songjaeng, A., Jairungsri, A., Puttikhunt, C., Kasinrerk, W., Malasit, P., Sittisombut, N., 2004. Alterations of pr- M cleavage and virus export in pr-M junction chimeric dengue viruses. J. Virol. 78, 2367-2381.
79. Kibler, K.V., Miyazato, A., Yedavalli, V.S., Dayton, A.I., Jacobs, B.L., Dapolito, G., Kim, S.J., Jeang, K.T., 2004. Polyarginine inhibits gp160 processing by furin and suppresses productive human immunodeficiency virus type 1 infection. J. Biol. Chem. 279, 49055-49063.
80. Kido, H., Okumura, Y., Takahashi, E., Pan, H.Y., Wang, S., Yao, D., Yao, M., Chida, J., Yano, M., 2012. Role of host cellular proteases in the pathogenesis of influenza and influenza-induced multiple organ failure. Biochim. Biophys. Acta 1824, 186-194.
81. Klenk, H.D., Garten, W., 1994. Host cell proteases controlling virus pathogenicity. Trends Microbiol. 2, 39-43.
82. Klenk, H.D., Rott, R., Orlich, M., Blodorn, J., 1975. Activation of influenza A viruses by trypsin treatment. Virology 68, 426-439.
83. Kunz, S., Edelmann, K.H., de la Torre, J.C., Gorney, R., Oldstone, M.B., 2003. Mechanisms for lymphocytic choriomeningitis virus glycoprotein cleavage, transport, and incorporation into virions. Virology 314, 168-178.
84. Kwong, P.D., Wyatt, R., Robinson, J., Sweet, R.W., Sodroski, J., Hendrickson, W.A., 1998. Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody. Nature 393, 648-659.
85. Lamb, R.A., Kolakofsky, D., 2001. Paramyxoviridae: the viruses and their replication. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology. Lippincott Williams & Wilkins, Philadelphia.
86. Lenz, O., Ter Meulen, J., Klenk, H.D., Seidah, N.G., Garten, W., 2001. The Lassa virus glycoprotein precursor GP-C is proteolytically processed by subtilase SKI-1/S1P. Proc. Natl. Acad. Sci. USA 98, 12701-12705.
87. Li, L., Lok, S.M., Yu, I.M., Zhang, Y., Kuhn, R.J., Chen, J., Rossmann, M.G., 2008. The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science 319, 1830-1834.
88. Lindenbach, B.D., Thiel, H.J., Rice, C.M., 2007. Field's Virology. Lippincott, Williams and Wilkins, Philadelphia.
89. Maisa, A., Stroher, U., Klenk, H.D., Garten, W., Strecker, T., 2009. Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 proteaseadapted alpha(1)-antitrypsin variants. PLoS Negl. Trop. Dis. 3, e446.
90. Morrison, T.G., 2003. Structure and function of a paramyxovirus fusion protein. Biochim. Biophys. Acta 1614, 73-84.
91. Morse, S.S., Mazet, J.A., Woolhouse, M., Parrish, C.R., Carroll, D., Karesh, W.B., Zambrana-Torrelio, C., Lipkin, W.I., Daszak, P., 2012. Prediction and prevention of the next pandemic zoonosis. Lancet 380, 1956-1965.
92. Moss, W.J., Griffin, D.E., 2012. Measles. Lancet 379, 153-164.
93. Moulard, M., Montagnier, L., Bahraoui, E., 1994. Effects of calcium ions on proteolytic processing of HIV-1 gp160 precursor and on cell fusion. FEBS Lett. 338, 281-284.
94. Moulard, M., Hallenberger, S., Garten, W., Klenk, H.D., 1999. Processing and routage of HIV glycoproteins by furin to the cell surface. Virus Res. 60, 55-65.
95. Neumann, G., Noda, T., Kawaoka, Y., 2009. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459, 931-939.
96. Nour, N., Basak, A., Chretien, M., Seidah, N.G., 2003. Structure-function analysis of the prosegment of the proprotein convertase PC5A. J. Biol. Chem. 278, 2886- 2895
97. Okumura, Y., Takahashi, E., Yano, M., Ohuchi, M., Daidoji, T., Nakaya, T., Bottcher, E., Garten, W., Klenk, H.D., Kido, H., 2010. Novel type II transmembrane serine proteases, MSPL and TMPRSS13, Proteolytically activate membrane fusion activity of the hemagglutinin of highly pathogenic avian influenza viruses and induce their multicycle replication. J. Virol. 84, 5089-5096.
98. Oldstone, M.B., 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. In: Oldstone, M.B. (Ed.), Arenaviruses, Vol. 263. Springer, pp. 83- 118.
99. Oliva, R., Leone, M., Falcigno, L., D'Auria, G., Dettin, M., Scarinci, C., Di Bello, C., Paolillo, L., 2002. Structural investigation of the HIV-1 envelope glycoprotein gp160 cleavage site. Chemistry 8, 1467-1473.
100. Ozden, S., Lucas-Hourani, M., Ceccaldi, P.E., Basak, A., Valentine, M., Benjannet, S., Hamelin, J., Jacob, Y., Mamchaoui, K., Mouly, V., Despres, P., Gessain, A., Butler-Browne, G., Chretien, M., Tangy, F., Vidalain, P.O., Seidah, N.G., 2008. Inhibition of Chikungunya virus infection in cultured human muscle cells by furin inhibitors: impairment of the maturation of the E2 surface glycoprotein. J. Biol. Chem. 283, 21899-21908.
101. Pager, C.T., Dutch, R.E., 2005. Cathepsin L is involved in proteolytic processing of the Hendra virus fusion protein. J. Virol. 79, 12714-12720.
102. Pager, C.T., Craft Jr., W.W., Patch, J., Dutch, R.E., 2006. A mature and fusogenic form of the Nipah virus fusion protein requires proteolytic processing by cathepsin L. Virology 346, 251-257.
103. Pasqual, G., Burri, D.J., Pasquato, A., de la Torre, J.C., Kunz, S., 2011. Role of the host cell's unfolded protein response in arenavirus infection. J. Virol. 85, 1662-1670.
104. Pasquato, A., Seidah, N.G., 2008. The H5N1 influenza variant Fujian-like hemagglutinin selected following vaccination exhibits a compromised furin cleavage: neurological consequences of highly pathogenic Fujian H5N1 strains. J. Mol. Neurosci. 35, 339-343.
105. Pasquato, A., Pullikotil, P., Asselin, M.C., Vacatello, M., Paolillo, L., Ghezzo, F., Basso, F., Di Bello, C., Dettin, M., Seidah, N.G., 2006. The proprotein convertase SKI-1/ S1P. In vitro analysis of Lassa virus glycoprotein-derived substrates and ex vivo validation of irreversible peptide inhibitors. J. Biol. Chem. 281, 23471-23481.
106. Pasquato, A., Dettin, M., Basak, A., Gambaretto, R., Tonin, L., Seidah, N.G., Di Bello, C., 2007. Heparin enhances the furin cleavage of HIV-1 gp160 peptides. FEBS Lett. 581, 5807-5813.
107. Pasquato, A., Burri, D.J., Traba, E.G., Hanna-El-Daher, L., Seidah, N.G., Kunz, S., 2011. Arenavirus envelope glycoproteins mimic autoprocessing sites of the cellular proprotein convertase subtilisin kexin isozyme-1/site-1 protease. Virology 417, 18-26.
108. Pasquato, A., Rochat, C., Burri, D.J., Pasqual, G., de la Torre, J.C., Kunz, S., 2012. Evaluation of the anti-arenaviral activity of the subtilisin kexin isozyme-1/site- 1 protease inhibitor PF-429242. Virology 423, 14-22.
109. Pinter, A., Honnen, W.J., Tilley, S.A., 1993. Conformational changes affecting the V3 and CD4-binding domains of human immunodeficiency virus type 1 gp120 associated with env processing and with binding of ligands to these sites. J. Virol. 67, 5692-5697.
110. Piper, D.E., Jackson, S., Liu, Q., Romanow, W.G., Shetterly, S., Thibault, S.T., Shan, B., Walker, N.P., 2007. The crystal structure of PCSK9: a regulator of plasma LDLcholesterol. Structure 15, 545-552.
111. Popkin, D.L., Teijaro, J.R., Sullivan, B.M., Urata, S., Rutschmann, S., de la Torre, J.C., Kunz, S., Beutler, B., Oldstone, M., 2011. Hypomorphic mutation in the site-1 protease Mbtps1 endows resistance to persistent viral infection in a cell-specific manner. Cell Host Microbe 9, 212-222.
112. Puente, X.S., Sanchez, L.M., Overall, C.M., Lopez-Otin, C., 2003. Human and mouse proteases: a comparative genomic approach. Nat. Rev. Genet. 4, 544-558.
113. Pullikotil, P., Vincent, M., Nichol, S.T., Seidah, N.G., 2004. Development of proteinbased inhibitors of the proprotein of convertase SKI-1/S1P: processing of SREBP-2, ATF6, and a viral glycoprotein. J. Biol. Chem. 279, 17338-17347.
114. Pullikotil, P., Benjannet, S., Mayne, J., Seidah, N.G., 2007. The proprotein convertase SKI-1/S1P: alternate translation and subcellular localization. J. Biol. Chem. 282, 27402-27413.
115. Rawling, J., Cano, O., Garcin, D., Kolakofsky, D., Melero, J.A., 2011. Recombinant Sendai viruses expressing fusion proteins with two furin cleavage sites mimic the syncytial and receptor-independent infection properties of respiratory syncytial virus. J. Virol. 85, 2771-2780.
116. Rehemtulla, A., Kaufman, R.J., 1992. Preferred sequence requirements for cleavage of pro-von Willebrand factor by propeptide-processing enzymes. Blood 79, 2349-2355.
117. Remacle, A.G., Chekanov, A.V., Golubkov, V.S., Savinov, A.Y., Rozanov, D.V., Strongin, A.Y., 2006. O-glycosylation regulates autolysis of cellular membrane type-1 matrix metalloproteinase (MT1-MMP). J. Biol. Chem. 281, 16897-16905.
118. Rojek, J.M., Lee, A.M., Nguyen, N., Spiropoulou, C.F., Kunz, S., 2008. Site 1 protease is required for proteolytic processing of the glycoproteins of the South American hemorrhagic fever viruses Junin, Machupo, and Guanarito. J. Virol. 82, 6045- 6051.
119. Rojek, J.M., Pasqual, G., Sanchez, A.B., Nguyen, N.T., de la Torre, J.C., Kunz, S., 2010. Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses. J. Virol. 84, 573-584.
120. Rousselet, E., Benjannet, S., Hamelin, J., Canuel, M., Seidah, N.G., 2011. The proprotein convertase PC7: unique zymogen activation and trafficking pathways. J. Biol. Chem. 286, 2728-2738.
121. Salvas, A., Benjannet, S., Reudelhuber, T.L., Chretien, M., Seidah, N.G., 2005. Evidence for proprotein convertase activity in the endoplasmic reticulum/early Golgi. FEBS Lett. 579, 5621-5625.
122. Sanchez, A.J., Vincent, M.J., Nichol, S.T., 2002. Characterization of the glycoproteins of Crimean-Congo hemorrhagic fever virus. J. Virol. 76, 7263-7275.
123. Sanchez, A.J., Vincent, M.J., Erickson, B.R., Nichol, S.T., 2006. Crimean-congo hemorrhagic fever virus glycoprotein precursor is cleaved by Furin-like and SKI-1 proteases to generate a novel 38-kilodalton glycoprotein. J. Virol. 80, 514- 525.
124. Scheid, A., Choppin, P.W., 1974. Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis, and infectivity of proteolytic cleavage of an inactive precursor protein of Sendai virus. Virology 57, 475-490.
125. Scheid, A., Choppin, P.W., 1977. Two disulfide-linked polypeptide chains constitute the active F protein of paramyxoviruses. Virology 80, 54-66.
126. Seidah, N.G., 2011. The proprotein convertases, 20 years later. Methods Mol. Biol. 768, 23-57.
127. Seidah, N.G., Prat, A., 2002. Precursor convertases in the secretory pathway, cytosol and extracellular milieu. Essays Biochem. 38, 79-94.
128. Seidah, N.G., Prat, A., 2007. The proprotein convertases are potential targets in the treatment of dyslipidemia. J. Mol. Med. (Berl) 85, 685-696.
129. Seidah, N.G., Prat, A., 2012. The biology and therapeutic targeting of the proprotein convertases. Nat. Rev. Drug Discov. 11, 367-383.
130. Seidah, N.G., Benjannet, S., Wickham, L., Marcinkiewicz, J., Jasmin, S.B., Stifani, S., Basak, A., Prat, A., Chretien, M., 2003. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc. Natl. Acad. Sci. USA 100, 928-933.
131. Seregin, S.V., Samokhvalov, E.I., Petrova, I.D., Vyshemirskii, O.I., Samokhvalova, E.G., Lvov, D.K., Gutorov, V.V., Tyunnikov, G.I., Shchelkunov, S.N., Netesov, S.V., Petrov, V.S., 2004. Genetic characterization of the M RNA segment of Crimean- Congo hemorrhagic fever virus strains isolated in Russia and Tajikistan. Virus Genes 28, 187-193.
132. Shiryaev, S.A., Remacle, A.G., Ratnikov, B.I., Nelson, N.A., Savinov, A.Y., Wei, G., Bottini, M., Rega, M.F., Parent, A., Desjardins, R., Fugere, M., Day, R., Sabet, M., Pellecchia, M., Liddington, R.C., Smith, J.W., Mustelin, T., Guiney, D.G., Lebl, M., Strongin, A.Y., 2007. Targeting host cell furin proprotein convertases as a therapeutic strategy against bacterial toxins and viral pathogens. J. Biol. Chem. 282, 20847-20853.
133. Simoes, E.A., 1999. Respiratory syncytial virus infection. Lancet 354, 847-852. Skehel, J.J., Wiley, D.C., 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569.
134. Skehel, J.J., Wiley, D.C., 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69, 531-569.
135. Staples, J.E., Breiman, R.F., Powers, A.M., 2009. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin. Infect. Dis. 49, 942-948.
136. Steinhauer, D.A., 1999. Role of hemagglutinin cleavage for the pathogenicity of influenza virus. Virology 258, 1-20.
137. Stieneke-Grober, A., Vey, M., Angliker, H., Shaw, E., Thomas, G., Roberts, C., Klenk, H.D., Garten, W., 1992. Influenza virus hemagglutinin with multibasic cleavage site is activated by furin, a subtilisin-like endoprotease. EMBO J. 11, 2407-2414.
138. Stroher, U., Willihnganz, L., Jean, F., Feldmann, H., 2007. Blockage of filoviral glycoprotein processing by use of a protein-based inhibitor. J. Infect. Dis. 196 (Suppl. 2), S271-S275.
139. Tanaka, S., Kurabuchi, S., Mochida, H., Kato, T., Takahashi, S., Watanabe, T., Nakayama, K., 1996. Immunocytochemical localization of prohormone convertases PC1/PC3 and PC2 in rat pancreatic islets. Arch. Histol. Cytol. 59, 261-271.
140. Toure, B.B., Munzer, J.S., Basak, A., Benjannet, S., Rochemont, J., Lazure, C., Chretien, M., Seidah, N.G., 2000. Biosynthesis and enzymatic characterization of human SKI-1/S1P and the processing of its inhibitory prosegment. J. Biol. Chem. 275, 2349-2358.
141. Turk, B., 2006. Targeting proteases: successes, failures and future prospects. Nat. Rev. Drug Discov. 5, 785-799.
142. Urata, S., Yun, N., Pasquato, A., Paessler, S., Kunz, S., de la Torre, J.C., 2011. Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease. J. Virol. 85, 795-803.
143. Van Rompaey, L., Ayoubi, T., Van De Ven, W., Marynen, P., 1997. Inhibition of intracellular proteolytic processing of soluble proproteins by an engineered alpha 2-macroglobulin containing a furin recognition sequence in the bait region. Biochem. J. 326 (Pt 2), 507-514.
144. Vincent, M.J., Sanchez, A.J., Erickson, B.R., Basak, A., Chretien, M., Seidah, N.G., Nichol, S.T., 2003. Crimean-Congo hemorrhagic fever virus glycoprotein proteolytic processing by subtilase SKI-1. J. Virol. 77, 8640-8649.
145. Watanabe, M., Hirano, A., Stenglein, S., Nelson, J., Thomas, G., Wong, T.C., 1995. Engineered serine protease inhibitor prevents furin-catalyzed activation of the fusion glycoprotein and production of infectious measles virus. J. Virol. 69, 3206-3210.
146. Weaver, S.C., Reisen, W.K., 2010. Present and future arboviral threats. Antiviral Res. 85, 328-345.
147. Willey, R.L., Klimkait, T., Frucht, D.M., Bonifacino, J.S., Martin, M.A., 1991. Mutations within the human immunodeficiency virus type 1 gp160 envelope glycoprotein alter its intracellular transport and processing. Virology 184, 319-329.
148. Wilson, I.A., Skehel, J.J., Wiley, D.C., 1981. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution. Nature 289, 366- 373.
149. York, J., Romanowski, V., Lu, M., Nunberg, J.H., 2004. The signal peptide of the Junin arenavirus envelope glycoprotein is myristoylated and forms an essential subunit of the mature G1-G2 complex. J. Virol. 78, 10783- 10792.
150. Yu, I.M., Zhang, W., Holdaway, H.A., Li, L., Kostyuchenko, V.A., Chipman, P.R., Kuhn, R.J., Rossmann, M.G., Chen, J., 2008. Structure of the immature dengue virus at low pH primes proteolytic maturation. Science 319, 1834-1837.
151. Zambon, M.C., 1999. Epidemiology and pathogenesis of influenza. J. Antimicrob. Chemother. 44 (Suppl. B), 3-9.
152. Zhang, X., Fugere, M., Day, R., Kielian, M., 2003. Furin processing and proteolytic activation of Semliki Forest virus. J. Virol. 77, 2981-2989.
153. Zhang, Y., Sun, Y., Sun, H., Pu, J., Bi, Y., Shi, Y., Lu, X., Li, J., Zhu, Q., Gao, G.F., Yang, H., Liu, J., 2012. A single amino acid at the hemagglutinin cleavage site contributes to the pathogenicity and neurovirulence of H5N1 influenza virus in mice. J. Virol. 86, 6924-6931.
154. Zhong, M., Munzer, J.S., Basak, A., Benjannet, S., Mowla, S.J., Decroly, E., Chretien, M., Seidah, N.G., 1999. The prosegments of furin and PC7 as potent inhibitors of proprotein convertases. In vitro and ex vivo assessment of their efficacy and selectivity. J. Biol. Chem. 274, 33913-33920.